市場調查報告書
商品編碼
1198009
氣動止血帶市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)Pneumatic Tourniquets Market - Growth, Trends, and Forecasts (2023 - 2028) |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
在預測期內(2022 年至 2027 年),氣動止血帶市場預計將以 7.1% 左右的複合年增長率增長。
COVID-19 引發了全球突發公共衛生事件,幾乎影響到每一個企業和行業。 預計長期影響將影響預測期內行業的增長。 鎖定期間對擇期手術的限制和供應鏈中斷影響了全球外科手術市場,對市場產生了負面影響。
題為“WALANT 技術與局部區域麻醉在掌骨和指骨骨折手術治療中的比較”的文章發表於 2021 年 12 月。 根據 COVID-19 危機的教訓,在 COVID-19 大流行期間,Wide Awake Local Anesthesia No Tourniquet (WALANT) 是一種避免使用止血帶並允許局部注射麻醉劑和腎上腺素的麻醉技術。 這種 WALANT 已被證明是一種安全有效的手部骨折手術方法,可確保根據 COVID-19 進行手術治療。 為了避免病毒傳播,護理中心採取了替代措施,這對所研究的市場產生了負面影響。
然而,近年來,骨科和整形手術數量的增加、意外事故和跌倒的激增,以及隨之而來的退行性骨病患病率的上升,推動了研究市場的增長。 例如,由國家衛生服務 (NHS) 提供的“2020-21 年醫院事故和緊急情況活動”指出,2020-21 年將有 1440 萬人到 NHS 醫院事故和緊急情況 (A&E) 部門就診。事實已經如此。 由於此類事故導致的緊急住院負擔增加,預計將增加對傷口護理手術的需求,從而推動對無血乾式手術氣動止血帶的需求。 預計這將促進所研究市場的增長。
此外,氣動止血帶在世界各地的手足手術中得到常規和安全的使用。 使用這些止血帶會改變正常的生理機能。 這些止血帶的使用是骨科和整形外科的常見做法。 骨科手術和其他增強手術的興起預計將推動靜脈局部麻醉 (IVRA),從而推動所研究市場的增長。
此外,最近大公司的收購和戰略行動增加了對氣動止血帶的需求。 例如,2020 年,Research & Dutrillaux 收購了 Electro Concept Medical,以集中其研發、生產和分銷技能。 這些領先公司的戰略活動預計將推動所研究市場的增長。
但是,預計在手術期間缺乏熟練的專業人員來處理該系統,這將阻礙預測期內的市場增長。
氣動止血帶可以最大限度地減少動脈暴露、夾層和操作,並可以降低因夾緊脛骨血管而引起痙攣和受傷的風險。 這些止血帶通常用於肢體手術,例如骨科和整形外科。
由於骨科疾病和其他退行性骨病的增加,預計在預測期內,按應用劃分的骨科手術領域將隨著增長而增長。 預計這些疾病需要更好的手術護理,以提供乾燥的手術野並限制肢體手術期間的術中出血。 因此,這有望推動所研究市場的增長。
這一細分市場的增長預計將受到骨關節炎等目標疾病患病率上升以及膝關節和髖關節置換手術數量增加的推動。 經濟合作與發展組織 (OECD) 於 2021 年 11 月更新的健康統計數據顯示,意大利每 10 萬人中進行了超過 193.9 次髖關節置換手術。 另一方面,奧地利、瑞士和比利時同年分別進行了每10萬人口294.9、312.9和283.3次髖關節置換手術。
此外,根據加拿大健康信息研究所2021年6月的更新報告,2019年至2020年,加拿大共有63,496例髖關節置換術和7例膝關節置換術,據說已經進行了5,073例。 與上一年相比,這意味著髖關節增加了 2.4%,膝關節減少了 0.4%。 因此,全球骨科疾病患病率上升預計將推動該行業的增長。
因此,骨科手術的應用正在增長,預計在預測期內將出現顯著增長。 因此,它正在推動研究市場的增長。
該地區老年人口的增加、醫療基礎設施、更好的報銷政策以及骨科和其他疾病負擔的增加等因素預計將推動北美氣動止血帶市場的增長。
氣動止血帶常用於骨科手術,以實現近乎不流血的手術和最佳手術野,或在手術過程中提供局部麻醉。 根據美國疾病控制與預防中心 (CDC) 於 2021 年 10 月更新的《全國關節炎數據與統計》,美國 (US) 約有四分之一的成年人 (23.7%),即約 5850 萬人,是醫生。據報導被診斷出患有關節炎 到 2040 年,美國 7840 萬 18 歲及以上的成年人(佔成年人口總數的 25.9%)將被醫生診斷為關節炎。 預計這將增加骨科手術的機會,並推動該國研究市場的增長。
此外,美國在建設和擴建醫院方面投入更多。 例如,2021 年 10 月,麻省總醫院獲得波士頓規劃和發展委員會的批准,擴建 100 萬平方英尺,耗資 20 億美元。 此外,2021 年 10 月,Penn Medicine 完成了美國最大的醫院項目之一,耗資 16 億美元在費城開設了一家醫院。 這些醫院擴建和建設支出的增加預計將創造對醫療設備的需求,並推動該國研究市場的增長。
此外,骨關節炎是一種退行性疾病,會隨著時間的推移而惡化,並且通常會導致慢性疼痛。 The Arthritis Facts and Figures,2021 年 9 月更新,由關節炎協會出版,發現骨關節炎是最常見的關節炎形式,超過 400 萬加拿大人患有骨關節炎 (OA)。據報導,大約每 7 名加拿大人中就有 1 人成年人患有這種進行性和痛苦的疾病。 消息人士還提到,超過 30% 的受試者被診斷出不僅患有 OA,還患有情緒障礙和焦慮症。 預計此類骨退行性疾病的流行將推動對根治性骨科手術的需求。 由於氣動止血帶主要用於骨科手術,預計骨科手術的增加將增加對氣動止血帶的需求。 因此,預計它將推動加拿大調查市場的增長。
因此,由於上述因素,預計北美地區在預測期內將呈現強勁增長,從而推動研究市場的增長。
在當前情況下,市場參與者不斷增加的策略正在推動全球空氣止血帶市場。 由於存在數量有限的大型參與者,該市場本質上具有競爭性,並且在全球範圍內得到整合。 Stryker、Zimmer Biomet、Ulrich medical、AneticAid、VBM Medizintechnik GmbH、Dessillions & Dutrillaux (D&D)、DSMAREF、Hangzhou Kimislab、Shanghai HSBC Medical Equipment、Jiangsu Qianjing Medical Equipment等均處於領先地位。
The pneumatic tourniquets market is anticipated to witness a CAGR of nearly 7.1% during the forecast period (2022-2027).
COVID-19 has created a global public health emergency that has affected almost every business and industry. The long-term effects are projected to have an impact on the industry growth during the forecast period. Limitations on elective surgical procedures and disruption of the supply chain during lockdown have affected the market for surgical procedures worldwide and impacted the market negatively.
An article published in December 2021 titled "WALANT technique versus locoregional anesthesia in the surgical management of metacarpal and phalangeal fractures: Lessons from the COVID-19 crisis, the COVID-19 pandemic" mentioned that Wide Awake Local Anesthesia No Tourniquet (WALANT) is an anesthetic method that enables the use of a local injection of anesthetic and epinephrine, avoiding the use of a tourniquet. This WALANT proved to be a safe and effective method in hand fracture surgery, ensuring access to surgical care in the COVID-19 perspective. To avoid the spread of the virus, care centers have approached alternatives that impacted the studied market negatively.
However, the increasing number of orthopedic and plastic surgeries performed, the surge in accidental injuries and falls, and the subsequent rise in the prevalence of degenerative bone diseases have driven the studied market growth in recent years. For instance, "Hospital Accident & Emergency Activity, 2020-21", provided by National Health Services (NHS), states that in the year 2020-21, there were 14.4 million attendances in Accident and Emergency (A&E) departments in NHS hospitals. This increasing burden of accident emergency admissions is anticipated to increase the demand for wound care surgeries, hence driving the demand for pneumatic tourniquets for bloodless and dry surgical procedures. This is expected to boost the growth of the studied market.
Furthermore, pneumatic tourniquets are routinely and safely used in limb surgeries throughout the world. The application of these tourniquets alters normal physiology. The use of these tourniquets is a common practice in orthopedic and plastic surgeries. The increase in plastic surgery and other augmentation procedures is anticipated to drive intravenous regional anesthesia (IVRA), driving the growth of the studied market.
Moreover, recent acquisitions and strategic steps taken by major players are increasing the demand for pneumatic tourniquets. For instance, in 2020, Dessillions & Dutrillaux acquired Electro Concept Medical to pool the skills of research and development, production, and distribution. These strategic activities by major players in anticipated to drive the growth of the studied market.
However, the lack of skilled professionals to handle the systems during the surgery is anticipated to hinder the market growth over the forecast period.
The pneumatic tourniquets allow for minimal exposure, dissection, and handling of the arteries, and it may decrease the risk of spasms or injury caused by clamping of the tibial vessels. These tourniquets are generally used in limb surgeries, be it orthopedic or plastic surgeries.
The orthopedic surgery by application segment is anticipated to witness growth over the forecast period owing to increasing orthopedic conditions and other degenerative bone diseases. Both the prevalence is expected to demand better surgical care, which can provide a dry operative field and limit intraoperative blood loss during extremity surgery. Hence, this is expected to drive the growth of the studied market.
The growth of the segment is likely to be fueled by the rising prevalence of target conditions such as osteoarthritis and the growing number of knee and hip replacement surgeries. The Organization for Economic Co-operation and Development (OECD) Health statistics data updated in November 2021 shows that there were over 193.9 hip replacement surgeries performed per 100,000 population in Italy. While over 294.9, 312.9, and 283.3 hip replacement surgeries were performed per 100,000 population in Austria, Switzerland, and Belgium, respectively, in the same year.
In addition to that, the Canadian Institute for Health Information's updates from June 2021 report shows that in 2019-2020 in Canada, 63,496 hip replacements and 75,073 knee replacements were performed. This represents a 2.4% increase for hips and a 0.4% decrease for knees compared with the previous years. This rising prevalence of orthopedic conditions worldwide is anticipated to drive the growth of the segment.
Hence, the orthopedic surgery by application segment is growing, and it is expected to have significant growth over the forecast period. Hence, driving the growth of the studied market.
Factors such as the increasing geriatric population across the region, healthcare infrastructure, better reimbursement policies, and the increasing burden of orthopedics and other diseases are anticipated to drive the growth of the North American pneumatic tourniquet market.
The pneumatic tourniquets are commonly used in orthopedic surgeries to achieve a nearly bloodless surgery and an optimal operating field or when administering regional anesthesia during surgery. The National Arthritis Data and Statistics updated in October 2021 by the Centre for Disease Control and Prevention (CDC) reported that about 1 in 4 adults (23.7%) or about 58.5 million people have doctor-diagnosed arthritis in the United States (US). The source also stated that, by the year ended 2040, 78.4 million adults aged 18 years and older (25.9% of the projected total adult population) are expected to have doctor-diagnosed arthritis in the US. This is expected to create opportunities for more orthopedic surgeries, driving the growth of the studied market in the country.
Moreover, the expenditure on hospital construction and expansion is increasing in the United States. For instance, in October 2021, Massachusetts General Hospital received approval from the Boston Planning and Development Agency board for a one-million-square-foot with USD 2 billion expansion. In addition to that, in October 2021, Penn Medicine opened a hospital in Philadelphia worth USD 1.6 billion, which marked the completion of one of the largest hospital projects in the United States. These rising expenditure on the expansion and construction of hospitals is expected to generate demand for medical devices and are anticipated to drive the growth of the studied market in the country.
Furthermore, osteoarthritis is a degenerative disease that worsens over time and often results in chronic pain. The Arthritis Facts and Figures updated in September 2021, published by the Arthritis Society, reported that osteoarthritis is the most common form of arthritis, and more than 4 million Canadians have osteoarthritis (OA), and about 1 in 7 Canadian adults live with this progressive and painful disease. The source also mentioned that more than 30% target population is diagnosed with a mood or anxiety disorder as well as OA. This prevalence of the degenerative bone disease is anticipated to drive the demand for orthopedic surgeries for treatment. As pneumatic tourniquets have the primary application in orthopedic surgeries, the increase in orthopedic surgeries is expected to increase the demand for pneumatic tourniquets. Hence, it is anticipated to drive the growth of the studied market in Canada.
Therefore, owing to the aforementioned factors, the North American region is expected to witness strong growth over the forecast period driving the growth of the studied market.
In the current scenario, the strategies by the market players are increasing, and it's fueling the global pneumatic tourniquet market. The market is competitive in nature and globally consolidated due to the presence of limited major players in the market. Stryker, Zimmer Biomet, Ulrich medical, AneticAid, VBM Medizintechnik GmbH, Dessillions & Dutrillaux (D&D), DSMAREF Co.Ltd., Hangzhou Kimislab Co., Ltd., Shanghai Huifeng Medical Instrument Co., Ltd., Jiangsu Qianjing Medical Equipment Co., Ltd are some of the major players among others.